TJ004309
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TJ004309, covering 2025-05-22 to 2025-12-16. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors [Phase 2]